microdosing glp 1 dose GLP-1s: Safety, Dosage, Side Effects, and Results Microdosing of GLP-1's / Wellness

Similarly, those switching from Zepbound to orforglipron experienced a 2.6 kg gain versus a 9.1 kg gain for placebo

The authors hope this case provides insights into the benefit of using GLP-1 agonists for genetic obesity syndromes

Dizziness related to GLP-1 therapy matters because it can affect medication adherence and quality of life during treatment initiation

Rare in clinical practice

In addition to the hormones GIP and glucagon, other hormones such as estrogen, peptide tyrosine tyrosine (PYY), gastrin, xenin, and fibroblast growth factor 21 can be good candidates to pair with GLP-1 and create dual agonists that have anti-diabetic and anti-obesity effects